CompletedNot Applicable

Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures

United States105 participantsStarted 2022-11-05

Plain-language summary

This Hybrid 1 Study will test the effectiveness of a bundled intervention comprised of behavioral activation and medication optimization in reducing symptoms of depression and anxiety in older adults undergoing cardiac surgery (compared with usual care), while examining implementation outcomes.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Adults ≥ 60 years * Scheduled major cardiac procedure * PHQ-ADS ≥ 10, indicating clinically significant depression or anxiety symptoms Exclusion criteria: * Barrier to communication (Unable to read, speak, and understand English) * Severe cognitive impairment screened by the SBT (Short Blessed Test) \>10 * Acutely suicidal * Previous participation in this study or CPMH feasibility study 202101103.

What they're measuring

PHQ-ADS

Timeframe: baseline and 3 months post-operatively

Trial details

NCT IDNCT05575128

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-20

Results submitted2026-03-11

View on ClinicalTrials.gov More Cardiac Surgery trials